High materiality7/10
Mirum Pharmaceuticals price target raised to $156 from $136 at Stifel
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Stifel raises Mirum Pharmaceuticals target to $156; current price $79.96.
- Stifel raises MIRM PT to $156; price $79.96.
Key facts
- 01
Target: $156
- 02
Posted price: $79.96
- 03
Analyst firm: Stifel Nicolaus
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.